11/14
08:12 am
sldb
Solid Biosciences to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Medium
Report
Solid Biosciences to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
11/14
08:00 am
sldb
Solid Biosciences to Present at the Jefferies London Healthcare Conference
Medium
Report
Solid Biosciences to Present at the Jefferies London Healthcare Conference
11/12
11:06 am
sldb
Solid Biosciences Inc. (NASDAQ: SLDB) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $12.00. They now have an "overweight" rating on the stock.
Low
Report
Solid Biosciences Inc. (NASDAQ: SLDB) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $12.00. They now have an "overweight" rating on the stock.
11/11
04:56 pm
sldb
Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $15.00 price target on the stock.
Medium
Report
Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $15.00 price target on the stock.
11/9
10:22 am
sldb
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate [Yahoo! Finance]
11/7
08:36 am
sldb
Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/6
04:05 pm
sldb
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates
Medium
Report
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates
11/4
08:00 am
sldb
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/31
08:00 am
sldb
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
Medium
Report
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
10/2
04:15 pm
sldb
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/23
08:00 am
sldb
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
Low
Report
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
9/12
08:00 am
sldb
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
Medium
Report
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
9/6
07:00 am
sldb
Solid Biosciences Inc. (NASDAQ: SLDB) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
Solid Biosciences Inc. (NASDAQ: SLDB) was upgraded by analysts at William Blair to a "strong-buy" rating.
9/4
04:05 pm
sldb
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/4
08:00 am
sldb
Solid Biosciences to Participate at Upcoming Investor Conferences
Medium
Report
Solid Biosciences to Participate at Upcoming Investor Conferences